The oral bioavailability, excretion and cytochrome P450 inhibition properties of epiberberine: an in vivo and in vitro evaluation

Chen, N; Yang, XY; Guo, CE; Bi, XN; Chen, JH; Chen, HY; Li, HP; Lin, HY; Zhang, YJ

Zhang, YJ (reprint author), Beijing Univ Chinese Med, Dept Chinese Mat Med, Sunshine South St, Beijing 102488, Peoples R China.

DRUG DESIGN DEVELOPMENT AND THERAPY, 2018; 12 (): 57

Abstract

Epiberberine (EPI) is a novel and potentially effective therapeutic and preventive agent for diabetes and cardiovascular disease. To evaluate its pote......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索